ArticleBiomedical optics express2026
Sensitive detection of surface-mounted micrometer-thin cancer biomarkers and viruses using laser wave-mixing spectroscopy.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
We report laser wave-mixing spectroscopy as a highly sensitive and rapid absorption-based detection method for pancreatic and breast cancer biomarkers and viruses on surface-mounted micrometer-thin samples. Currently, cancer diagnosis is done mostly by imaging techniques such as magnetic resonance imaging (MRI) and computed tomography (CT), which typically are effective for detecting tumors only at later stages. Similarly, early viral detection, such as HIV, is challenged by the diagnostic window period. These limitations underscore the urgent need for more sensitive, rapid, and minimally invasive biomarker-based diagnostic tools. Our laser wave-mixing detection method offers significant advantages over existing techniques, including ultrasensitive detection, excellent chemical specificity, and high spatial resolution achieved through the use of small probe volumes (nL) and micrometer-thin samples that can be mounted on microscope slides and microarrays that can be reproducibly moved and controlled by piezo actuators. We achieved detection sensitivity for the pancreatic cancer biomarker CA 19-9 at micro-unit levels, and for HIV-1 p24 and HER-2 at zeptomole levels. Laser wave-mixing detection method provides excellent detection limits and high spatial resolution compared to traditional methods, making it an effective microchip-based detector for point-of-care diagnostics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.